Cargando…

High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34‐positive AML

Acute myeloid leukemia (AML) is driven by a minor fraction of leukemic stem cells (LSCs) whose persistence is considered being the primary cause of disease relapse. A detailed characterization of the surface immunophenotype of LSCs to discriminate them from bulk leukemic blasts may enable successful...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daga, Shruti, Rosenberger, Angelika, Quehenberger, Franz, Krisper, Nina, Prietl, Barbara, Reinisch, Andreas, Zebisch, Armin, Sill, Heinz, Wölfler, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488118/ https://www.ncbi.nlm.nih.gov/pubmed/30848055 http://dx.doi.org/10.1002/cam4.2053

Ejemplares similares

Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry‐based leukemic cell enrichment followed by mutational profiling
por: Daga, Shruti, et al.
Publicado: (2020)

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
por: Hatzl, Stefan, et al.
Publicado: (2020)

TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPα
por: Anirudh, Subramanian, et al.
Publicado: (2020)

Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
por: Müller, Marian, et al.
Publicado: (2019)

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
por: Pabst, Gabriel, et al.
Publicado: (2020)

Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs
por: Zebisch, Armin, et al.
Publicado: (2016)

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis
por: Caraffini, Veronica, et al.
Publicado: (2020)

Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities
por: Foßelteder, Johannes, et al.
Publicado: (2023)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019)

BRAF(V600E) promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis
por: Sconocchia, Tommaso, et al.
Publicado: (2023)

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing
por: Kashofer, Karl, et al.
Publicado: (2017)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
por: Prochazka, Katharina T., et al.
Publicado: (2019)

Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion
por: Chatterjee, Treena, et al.
Publicado: (2021)

Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression
por: Saha, Hasi Rani, et al.
Publicado: (2018)

The role of GPR56/ADGRG1 in health and disease
por: Singh, Abhishek Kumar, et al.
Publicado: (2021)

Role of ADGRG1/GPR56 in Tumor Progression
por: Ng, Kwai-Fong, et al.
Publicado: (2021)

Transcriptomics and Phenotypic Analysis of gpr56 Knockout in Zebrafish
por: Sun, Luning, et al.
Publicado: (2023)

The ESRP1-GPR137 axis contributes to intestinal pathogenesis
por: Mager, Lukas Franz, et al.
Publicado: (2017)

EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity
por: Berg, Johannes Lorenz, et al.
Publicado: (2021)

GPR56/ADGRG1 is associated with response to antidepressant treatment
por: Belzeaux, Raoul, et al.
Publicado: (2020)

Adhesion GPCR GPR56 Expression Profiling in Human Tissues
por: Kaiser, Fyn, et al.
Publicado: (2021)

Low-dose salinomycin induces anti-leukemic responses in AML and MLL
por: Roulston, Gary D.R., et al.
Publicado: (2016)

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
por: Valent, Peter, et al.
Publicado: (2019)

Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia
por: Berg, Johannes Lorenz, et al.
Publicado: (2021)

Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
por: Pagano, Ester, et al.
Publicado: (2022)

Disease-Associated Mutations Prevent GPR56-Collagen III Interaction
por: Luo, Rong, et al.
Publicado: (2012)

GPR56/ADGRG1 regulates development and maintenance of peripheral myelin
por: Ackerman, Sarah D., et al.
Publicado: (2018)

The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell
por: Huang, Kuan-Yeh, et al.
Publicado: (2018)

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
por: Haubner, S., et al.
Publicado: (2018)

β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells
por: Zhao, Xin, et al.
Publicado: (2020)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells
por: Trombly, Daniel J, et al.
Publicado: (2015)

Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
por: Cheng, Wing Yin, et al.
Publicado: (2016)

Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trial
por: Aberer, Felix, et al.
Publicado: (2018)

GPR34 in spinal microglia exacerbates neuropathic pain in mice
por: Sayo, Akira, et al.
Publicado: (2019)

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
por: Cloos, Jacqueline, et al.
Publicado: (2018)

Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
por: Zhang, Yongping, et al.
Publicado: (2023)

Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1
por: Xu, Xin, et al.
Publicado: (2020)

Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML
por: Kumar, Anita J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3kl433583legr9dhmlc5vd0hi1